Authors: ALDERMAN MH KIVLIGHN S BCAUCHARD L COHEN H MADHAVAN S

Citation: Mh. Alderman et al., INCREASED SERUM URIC-ACID ASSOCIATED WITH INCREASED CARDIOVASCULAR-DISEASE IN TREATED HYPERTENSIVE PATIENTS, Journal of hypertension, 16, 1998, pp. 21-21

Authors: NISHIKIBE M ISHIKAWA K FUKURODA T OHTA H KANOH T OZAKI S NOGUCHI K SAITO M UEHARA S WILLIAMS D KIVLIGHN S KRAUSE S GABEL R ZINGARO G NOLAN N OBRIEN J CLAYTON F LYNCH J PETTIBONE D SIEGL P

Citation: M. Nishikibe et al., PHARMACOLOGY OF J-104,132, A POTENT, ORALLY-ACTIVE, MIXED ETA ETB ENDOTHELIN RECEPTOR ANTAGONIST/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 5216-5216

Authors: GABEL R ZINGARO G NISHIKIBE M KIVLIGHN S SIEGL P

Citation: R. Gabel et al., ANTIHYPERTENSIVE EFFICACY OF J-104,132 (L753,037), A POTENT, ORALLY-ACTIVE, MIXED ETA ETB ENDOTHELIN RECEPTOR ANTAGONIST, IN CONSCIOUS, DOCA/SALT HYPERTENSIVE RATS/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3820-3820

Authors: FLAHERTY JT EDELMAN J KIVLIGHN S

Citation: Jt. Flaherty et al., EFFECTS OF A LOW-DOSE OF THIAZIDE DIURETIC ON SERUM URIC-ACID - COMPARISON OF A LOSARTAN-BASED REGIMEN VS USUAL CARE, Circulation, 98(17), 1998, pp. 3800-3800

Authors: SZABO Z MATHEWS WB BURNS HD GIBSON RE KIVLIGHN S HAMILL TG RAVERT HT DANNALS RF

Citation: Z. Szabo et al., COMPARISON OF THE PHARMACOLOGICAL POTENCY AND AT1 RECEPTOR OCCUPANCY OF THE NONPEPTIDE ANGIOTENSIN ANTAGONIST E-3174, The Journal of nuclear medicine, 37(5), 1996, pp. 1287-1287

Authors: KAYE AD NOSSAMAN BD KIVLIGHN S IBRAHIM IN DEWIT BJ KADOWITZ PJ

Citation: Ad. Kaye et al., RESPONSES TO L-163,491, A NONPEPTIDE ANGIOTENSIN-II MIMIC, IN THE PULMONARY VASCULAR BED OF THE CAT, European journal of pharmacology, 287(2), 1995, pp. 163-168